MED Share Price Performance
CHF 93.20
20.50 (28.20%)
4.5% undervalued intrinsic discount
CHF 97.63
Fair Value
Price CHF 93.20
AnalystConsensusTarget CHF 97.63
Fair ValueCHF 97.63
Share Pricen/a
Medartis Holding AG Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
MED Community Narratives
AN
Fair Value CHF 97.63 4.5% undervalued intrinsic discount
Orthopedic Demand And Digital Solutions Will Expand Global Reach
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Orthopedic Demand And Digital Solutions Will Expand Global Reach
Key Takeaways Expansion into high-growth global markets and advanced personalized implant solutions positions Medartis for greater revenue and margin gains in premium healthcare segments. Investments in operational efficiency and strong competitive barriers strengthen the company's stability and profitability amid industry and macroeconomic challenges.Read more
84
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
CHF 97.63
4.5% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
18.53% p.a.
Profit Margin
11.58%
Future PE
29.62x
Price in 2029
CHF 108.67
Trending Discussion
Recently Updated Narratives
AN
MED: CFO Succession And Recent Acquisitions Will Support A Stronger Outlook
Fair Value: CHF 97.63 4.5% undervalued intrinsic discount
3 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Medartis Holding AG Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 17, 2026
- -0.039
- 79.11%
- -0.21%
- 44.3%
About MED
- Founded
- 1997
- Employees
- 1158
- CEO
- WebsiteView website
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides osteosynthesis products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
